Is Melphalan/Melphalan reimbursed by medical insurance?

Melphalan/Melphalan (Melphalan) is a chemical drug that belongs to the alkalizing agent category. The common feature of these drugs is that they can add bases to the DNA chain, interfering with its normal DNA replication and cell division processes. This effect makes cancer cells unable to maintain their normal growth and proliferation.

Melphalan/Melphalan’s oral medicines and injections have been launched in China. The oral medicines have been included in the medical insurance, but the injections have not yet been included in the medical insurance. For specific prices and reimbursement, please consult the local hospital pharmacy and the local medical insurance bureau. Foreign original drugs include European original drugs and Turkish original drugs. European original drugs cost about more than a thousand yuan, and Turkish original drugs cost about a few hundred yuan. In addition, there are Indian generic drugs, the price of which is also around a few hundred yuan. The ingredients of original drugs and generic drugs are basically the same.

Melphalan/Melphalan is commonly used to treat a variety of malignant tumors, especially some leukemias and hematological malignancies involving bone marrow. These include multiple myeloma, lymphoma, ovarian cancer, and more. Melphalan/Melphalan plays a key role in the treatment of these diseases.

Melphalan/Melphalan’s mechanism of action involves introducing its molecules into the DNA chains of cancer cells, causing breakage and damage to the DNA chains. This damage will prevent the normal DNA replication and cell division of cancer cells, eventually leading to the death of cancer cells or the cessation of proliferation. This mechanism of action makes melphalan/melphalan an effective anticancer drug.

Melphalan/Melphalan can be given to patients as an oral drug or intravenously, and a doctor usually develops a personalized treatment plan based on the patient's specific situation and type of disease. However, Melphalan/MelphalanUse may be associated with a range of side effects, including nausea, vomiting, diarrhea, bone marrow suppression (low blood cells and thrombocytopenia), and possible risk of infection. Therefore, patients generally require close medical monitoring and supportive care during treatment with melphalan/melphalan to manage these side effects and ensure the safety and effectiveness of the treatment.